Xtant Medical Holdings, Inc. · AMEX:XTNT
Xtant Medical — Bacterin International Holdings — Investor Presentation (December 2013)
14 slides from Xtant Medical's investor presentation, December 2013
Slide 1: Investor Presentation
Investor Presentation December 2013 NYSE AMEX: BONE Investor Presentation NYSE MKT: BONE November 2012
Slide 2: Important Cautions Regarding Forward Looking Statements
Important Cautions Regarding Forward Looking Statements This presentation contains certain disclosures that may be deemed forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that are subject to significant risks and uncertainties. Forward-looking sta
Slide 3: Bacterin Snapshot
Bacterin Snapshot • Leading orthobiologics manufacturer focused on regenerative allografts • Proprietary technology that addresses the $3.0B biologics market • FDA registered, AATB accredited, and ISO certified • Scaffolds focused on superior handling characteristics and better outcomes • OsteoSpong
Slide 4: Bacterin Brands
Bacterin Brands DBM Putty 4 2013 © Bacterin International Holdings, Inc. All rights reserved.
Slide 5: Addressable Market Opportunity
Addressable Market Opportunity $3 Billion Total Addressable Market Opportunity in U.S. Soft Tissue Breast Recon Key Market Drivers ~$400M 13% Soft Tissue Bone • Increasing ‘Baby Boomer’ Wound ~$683M Repair population 22% $1.7B 56% • Changes in lifestyles and behaviors • Improved, less invasive Soft
Slide 6: Annual Procedures
US Bone Replacement Procedure Volumes 1,600,000 1,400,000 1,200,000 Annual Procedures 1,000,000 800,000 600,000 400,000 200,000 0 2012 2017E Thoracolumbar Spinal Fusion Cervical Spinal Fusion Foot/Ankle Hand/Wrist/Elbow Fracture Repair Surgery Total Joint Revision (Hip and Knee) Average biologics Sp
Slide 7: Bone Scaffolds
Bone Scaffolds DBM Putty • Bone filler for use where • Consists of demineralized • Thin sheet of cortical bone • Precision-milled cortical bone regeneration is bone and a carrier material that acts as a biologic plate bone desired • Will not leach or migrate • Easily bent, folded, or • Designed to s
Slide 8: DBM Putty
DBM Putty Posterior Lumbar Spine New Market Opportunity • Expanded Indication for Spine – Allows Bacterin to market OsteoSelect® DBM Placement of OsteoSelect DBM Putty Putty to Spine Surgeons for Posterolateral Spinal – Announced Q3 2013 Fusion • Pre-Clinical results have shown OsteoSelect® to be eq
Slide 9: Soft Tissue Market
Soft Tissue Market Plastic/Reconstructive US Breast Reconstruction Market ~$400M in 2012 • 90,000 Procedures performed in 2012 (ASPS) • Biologics spend per procedure ~$4,500 • Acellular Dermal Matrix derived from donated human tissue Image courtesy of Dr. Vip Dev MD • Provided Sterile 9 2013 © Bacte
Slide 10: Bacterin Key Growth Drivers
Bacterin Key Growth Drivers Future Scientific US Sales presence Peer Review Publications • 20 Direct Sales reps and 140 Distributors Spine • About 400 feet on the street Dr. Ames – Study Underway • GPO Physician Preference Supplier Drs. Girasole, Muro, Mintz– Published agreements: Foot & Ankle Dr. B
Slide 11: Summary Income Statement
Summary Income Statement FY FY Q1 Q2 Q3 (in US $ millions) 2011 2012 2013 2013 2013 Revenue $30.1 $33.0 $8.6 $8.3 $7.9 Gross Profit $21.0 $22.6 $5.5 $4.7 $4.6 Gross Margin 70% 69% 64% 57% 58% Adjusted EBITDA $(3.0) $(2.6) $(1.1) $(1.4) $(1.8) 11 2013 © Bacterin International Holdings, Inc. All right
Slide 12: Balance Sheet Highlights
Balance Sheet Highlights As of September 30, 2013 • Cash: $3.4 million • Accounts receivable: $4.6 million • Inventories, net: $13.2 million • $20 million venture debt facility provided by OrbiMed Advisors 12 2013 © Bacterin International Holdings, Inc. All rights reserved.
Slide 13: Bacterin Key Takeaways
Bacterin Key Takeaways • Leading orthobiologics company focused on skeletal and dermal health • Full catalog of bone and soft tissue scaffolds with the most clinical evidence in the category • 400 feet on the street detailing our product offering in the US. • Four national GPO relationships and • Si
Slide 14: Thank You
Thank You NYSE AMEX: BONE Investor Presentation NYSE MKT: BONE November 2012
Bacterin International Holdings — Investor Presentation (December 2013) on 6ix